BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18662272)

  • 1. Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis.
    Takeyama Y; Uehara Y; Inomata S; Morihara D; Nishizawa S; Ueda S; Matsumoto T; Tanaka T; Anan A; Nishimura H; Irie M; Iwata K; Shakado S; Sohda T; Sakisaka S
    Liver Int; 2009 Mar; 29(3):406-14. PubMed ID: 18662272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
    Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
    Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
    Chen HL; Liu YJ; Chen HL; Wu SH; Ni YH; Ho MC; Lai HS; Hsu WM; Hsu HY; Tseng HC; Jeng YM; Chang MH
    Pediatr Res; 2008 Jun; 63(6):667-73. PubMed ID: 18327154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.
    Wang AP; Migita K; Ito M; Takii Y; Daikoku M; Yokoyama T; Komori A; Nakamura M; Yatsuhashi H; Ishibashi H
    J Autoimmun; 2005 Aug; 25(1):85-91. PubMed ID: 16006099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.
    Denk GU; Soroka CJ; Takeyama Y; Chen WS; Schuetz JD; Boyer JL
    J Hepatol; 2004 Apr; 40(4):585-91. PubMed ID: 15030973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis.
    Medina JF; Martínez-Ansó ; Vazquez JJ; Prieto J
    Hepatology; 1997 Jan; 25(1):12-7. PubMed ID: 8985258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
    Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
    Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
    Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype.
    Gradhand U; Lang T; Schaeffeler E; Glaeser H; Tegude H; Klein K; Fritz P; Jedlitschky G; Kroemer HK; Bachmakov I; Anwald B; Kerb R; Zanger UM; Eichelbaum M; Schwab M; Fromm MF
    Pharmacogenomics J; 2008 Feb; 8(1):42-52. PubMed ID: 17404579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea.
    Balesaria S; Pell RJ; Abbott LJ; Tasleem A; Chavele KM; Barley NF; Khair U; Simon A; Moriarty KJ; Brydon WG; Walters JR
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):413-22. PubMed ID: 18403943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression profiles in stage I primary biliary cirrhosis.
    Honda M; Kawai H; Shirota Y; Yamashita T; Kaneko S
    Am J Gastroenterol; 2005 Sep; 100(9):2019-30. PubMed ID: 16128947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor agonists in biliary tract disease.
    Fiorucci S; Baldelli F
    Curr Opin Gastroenterol; 2009 May; 25(3):252-9. PubMed ID: 19300246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.
    Nakamura M; Takii Y; Ito M; Komori A; Yokoyama T; Shimizu-Yoshida Y; Koyabu M; Matsuyama M; Mori T; Kamihira T; Daikoku M; Migita K; Yatsuhashi H; Nozaki N; Shimoda S; Ishibashi H
    J Autoimmun; 2006 Mar; 26(2):138-45. PubMed ID: 16337775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFSF9 expression in primary biliary cirrhosis and its clinical significance.
    Xia R; Tang Y; Huang Y; Yao D; Zhou Y; Chen B; Chen Y; Chen S; Deng A; Zhong R
    Cytokine; 2010 Jun; 50(3):311-6. PubMed ID: 20303781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis.
    Kojima H; Nies AT; König J; Hagmann W; Spring H; Uemura M; Fukui H; Keppler D
    J Hepatol; 2003 Nov; 39(5):693-702. PubMed ID: 14568249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis.
    Onori P; Alvaro D; Floreani AR; Mancino MG; Franchitto A; Guido M; Carpino G; De Santis A; Angelico M; Attili AF; Gaudio E
    J Histochem Cytochem; 2007 Apr; 55(4):327-34. PubMed ID: 17164408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.